| Mike Snook, RPH | |
|
12250 Woodland Trl, Council Bluffs, IA 51503-6402 | |
| (712) 366-3826 | |
| Not Available |
| Full Name | Mike Snook |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 12250 Woodland Trl, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063780179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S16778 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mike Snook, RPH 2508 W Broadway, Council Bluffs, IA 51501-3509 Ph: (712) 328-2266 | Mike Snook, RPH 12250 Woodland Trl, Council Bluffs, IA 51503-6402 Ph: (712) 366-3826 |
News Archive
New data from a descriptive sub-analysis of patients with compensated liver cirrhosis show that up to 43 percent of genotype-1a (GT1a) and up to 71 percent of GT1b hepatitis C virus (HCV) patients achieved sustained viral response (SVR12). SVR12 has been highly correlated with SVR24, which is a recognized indicator of viral cure.
Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.
Discovery Laboratories, Inc. announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market indicating that, because the Company's common stock has not maintained a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, the Company is no longer in compliance with Nasdaq's Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement").
A new study shows that brain cells use a mix of analog and digital coding at the same time to communicate efficiently.
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project reports that a highly aggressive form of leukemia in infants has surprisingly few mutations beyond the chromosomal rearrangement that affects the MLL gene. The findings suggest that targeting the alteration is likely the key to improved survival.
› Verified 3 days ago
Michael Ryan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1141 N Broadway, Council Bluffs, IA 51503 Phone: 712-322-9019 Fax: 712-325-9731 | |
Mr. Lonnie Lemaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 W Bennett Ave, Council Bluffs, IA 51503 Phone: 712-325-0619 | |
Mr. William L Wettengel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Woodcliff Cir, Council Bluffs, IA 51503 Phone: 712-256-3836 | |
Constance Penzotti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 W Bennett Ave, Council Bluffs, IA 51503 Phone: 712-325-0619 | |
Dr. Laura Gless, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3221 Manawa Centre Dr, Council Bluffs, IA 51501 Phone: 712-366-7032 | |
Mrs. Kimberlee Jo Otto, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20697 Mcpherson Ave, Council Bluffs, IA 51503 Phone: 402-598-8868 |